Takeda Files Actos/Metformin Combination Actoplus Met For Type 2 Diabetes

NDA submission of pioglitazone/metformin combo marks beginning of Takeda’s expansion in the U.S. diabetes market; the firm has insulin resistance-improving agents in Phase II and Phase III.